WaveMan · Form 4
Mcgrath Dennis M insider trades
> Search tickers & screens ⌘K
LIVE

Mcgrath Dennis M insider trades

Mcgrath Dennis M has filed 21 Form 4s with the SEC that we hold, for DarioHealth Corp. (DRIO) (Director), Lucid Diagnostics Inc. (LUCD) (Chief Financial Officer), Citius Oncology, INC. (CTOR) (Director) and PAVmed Inc. (PAVM) (President and CFO), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 1 sale worth $39.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 9,872 shares of DarioHealth Corp. worth $39.2K, dated 2022-12-21. The first filing on our record is dated 2022-01-10 and the latest 2026-09-28.

DarioHealth Corp. (DRIO)

Director · 5 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-12-21S, sale reported on Form 49,872$39.2K2022-12-23

Lucid Diagnostics Inc. (LUCD)

Chief Financial Officer · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Citius Oncology, INC. (CTOR)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

PAVmed Inc. (PAVM)

President and CFO · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Citius Pharmaceuticals, Inc. (CTXR)

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1269340) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms